Table 1 The comparison of clinical and genetic features between HOXA10-high and HOXA10-low groups
From: Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
|  | HOXA10-low group (n = 72) | HOXA10-high group (n = 73) | p value |
|---|---|---|---|
Age (year) | 52.08 ± 17.592 | 56.63 ± 14.730 | 0.094 |
Gender | 0.739 | ||
 Female | 31 | 34 |  |
 Male | 41 | 39 |  |
Race | 0.717 | ||
 White | 50 | 53 |  |
 Other races | 22 | 20 |  |
Mutation count | 9.43 ± 5.897 | 9.63 ± 5.116 | 0.826 |
FAB subtype | < 0.0001 | ||
  M3 | 15 | 0 |  |
 non-M3 | 57 | 73 |  |
Risk stratification of cytogenetics | < 0.0001 | ||
 Good | 29 | 1 |  |
 Intermediate | 26 | 55 |  |
 Poor | 16 | 15 |  |
Risk stratification of molecular mutation | < 0.0001 | ||
 Good | 30 | 1 |  |
 Intermediate | 25 | 50 |  |
 Poor | 16 | 20 |  |
WBC | 28.693 ± 45.009 | 40.800 ± 36.862 | 0.078 |